Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases. The company serves patients, families, and advocates in the rare disease community through novel drug development and patient-centered approaches.
4 investors
HarmonyCares is a house call medical practice providing in-home primary and clinical care, lab tests, and X-rays for people with complex medical conditions. It serves patients, referral partners, and health plans across 12 U.S. states.
4 investors
Hedera Dx provides hospital in-house laboratories with a full suite of NGS genomic tumor profiling solutions, including FFPE, ctDNA and RNA-only testing, plus software that generates clinical reports linking tumor sequences to approved therapies. It also supports real-world evidence generation for health systems, patients and drug development programs, with a stated focus on European hospital laboratories.
4 investors
icometrix develops FDA-cleared, CE-marked AI software (icobrain) that quantifies and compares brain MRI scans over time to support radiologists and neurologists in diagnosing and monitoring neurological conditions such as multiple sclerosis and Alzheimer's disease. Now a GE HealthCare company, it serves hospitals and healthcare providers worldwide.
4 investors
Illuminant Surgical develops an AI-powered real-time anatomical projection system called Skylight for spine surgery and interventional procedures, using computer vision and projection mapping to display medical imaging directly onto patients. The system is designed for surgical professionals across hospitals, ambulatory surgical centers, and specialty clinics to improve surgical guidance and workflow efficiency.
4 investors
Imagen provides radiology services that combine subspecialist radiologists, medical imaging technology, and AI to help healthcare organizations produce faster and more accurate diagnostic reads. It serves healthcare organizations and radiologists in the medical imaging and diagnostics space.
4 investors
The page is a stock price information page (share price, trading volume, and market cap history) rather than a descriptive company page, so it provides no usable detail about what the company does.
4 investors
Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases. The company focuses on advancing treatments in cancer immunotherapy and inflammation-related conditions.
4 investors
InfoBionic.Ai develops a remote cardiac monitoring platform called MoMe ARC that combines AI-powered ECG analysis, interchangeable biosensors, and clinical analytics to enable hospital-grade cardiac telemetry outside traditional hospital settings. The platform serves hospitals and cardiac care facilities seeking to improve monitoring quality, detect arrhythmias like atrial fibrillation, and streamline remote patient management workflows.
4 investors
BETVIBE is an online gaming platform offering 3,000+ casino games and 50+ sports betting markets specifically designed for Indian players. The platform operates under Anjouan Gaming Commission licensing with INR payments, popular local payment methods, and aims to deliver fast withdrawal processing.
4 investors
InSilicoTrials provides a platform for clinical trial simulation and design optimization using mechanistic models, AI, and digital twins. The platform helps pharmaceutical companies, biotech firms, and regulators reduce development risk and accelerate the path from drug discovery to patient access.
4 investors
Instylla develops resorbable liquid embolic agents for interventional radiology and oncology, including the Embrace Hydrogel Embolic System and the Tembo Embolic System used to embolize hypervascular tumors and occlude peripheral blood vessels. Its products are used by physicians treating hypervascular tumors in the peripheral vasculature.
4 investors
Intercept Pharmaceuticals is a biopharmaceutical company developing medicines for rare and serious liver diseases, with research centered on Farnesoid X Receptor (FXR) biology for conditions such as severe alcohol-associated hepatitis. Founded in 2002, it is a wholly owned subsidiary of Alfasigma.
4 investors
Invirsa is a clinical-stage biopharmaceutical company developing DNA damage response therapeutics, with lead compound INV-102 in development for ocular conditions including sulfur mustard gas injury and diabetic dry eye disease.
4 investors
iSono Health develops an automated ultrasound system combined with artificial intelligence for breast imaging at the point of care, enabling standardized and accessible imaging across different healthcare settings.
4 investors
JuneBrain develops portable telehealth optical coherence tomography (OCT) devices paired with AI software for remote monitoring of neurological and retinal diseases. Its retinal imaging systems are aimed at researchers, clinical trials, and point-of-care providers in neurology and eye care.
4 investors
Kascaid is developing a wearable biosensor platform that measures immune biomarkers from interstitial fluid on demand, capturing immune activity through the skin. The technology targets clinical trials, research, and patient care to enable continuous, low-burden immune monitoring.
4 investors
The site is a Vietnamese-language affiliate/review portal that ranks and rates online lottery ("lΓ΄ Δα»") betting operators, offering comparisons of payout ratios, licensing, payment methods, and security. It targets Vietnamese online gamblers looking to choose betting sites.
4 investors
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis. Its products are aimed at healthcare professionals and patients, including veterans with chronic edema.
4 investors
Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors. The company operates in the medical field with a focus on clinical treatment solutions.
4 investors
LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease. It operates in the regenerative medicine and biomaterials category.
4 investors
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
4 investors
Lunit develops AI-powered cancer diagnostics and biomarker analysis tools used by hospitals and biopharmaceutical companies. Its FDA-cleared, clinically validated solutions are deployed across sites in more than 65 countries.
4 investors
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
4 investors